The gut microbiome plays a critical role in regulating human metabolism and health. Bug Speaks, a new initiative by the bioinformatics company Leucine Rich Bio, aims to utilize information gleaned from assessing the gut microbiome to predict disease susceptibility and provide personalized health recommendations.